Abiomed financials at a glance

Year Year 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$38.22M $43.67M $50.65M $58.94M $73.21M $85.71M $101.15M $126.38M $158.12M $183.64M $230.31M $329.54M $445.30M $593.75M $769.43M $840.88M $847.52M $1.03B $0.00M $0.00M
GM % Gross Margin %
75.49% 73.24% 75.95% 73.88% 71.43% 73.11% 78.27% 80.61% 80.02% 79.68% 82.66% 84.70% 84.14% 83.40% 83.16% 82.01% 80.90% 81.76% 0.00% 0.00%
OM Operating Margin
-8.51% -38.89% -54.71% -59.86% -40.32% -29.26% -11.06% 1.20% 10.46% 4.55% 12.67% 20.08% 20.60% 26.69% 29.10% 29.57% 27.48% 24.80% 0.00% 0.00%
EPS Earnings Per Share
$0.00 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
21.87m 26.34m 26.7m 32.51m 36.61m 37.01m 37.19m 38.56m 39.53m 39.28m 40.46m 42.42m 43.38m 44.22m 45.04m 45.16m 45.19m 45.5m 45.57m 0m
OCF Operating Cash Flow
$-5.16M $-9.34M $-19.82M $-28.87M $-18.31M $-7.36M $1.57M $3.63M $26.40M $23.47M $43.29M $76.80M $115.12M $192.55M $252.20M $314.92M $274.58M $285.39M $0.00M $0.00M
FCF Free Cash Flow
$-5.86M $-12.27M $-22.19M $-32.63M $-22.06M $-9.16M $-0.23M $1.88M $23.56M $20.71M $38.10M $61.18M $64.70M $136.69M $208.20M $270.91M $221.20M $249.63M $0.00M $0.00M
FCFS Free Cash Flow Per Share
$-0.27 $-0.48 $-0.82 $-1.01 $-0.63 $-0.25 $-0.01 $0.05 $0.60 $0.53 $0.94 $1.45 $1.50 $3.10 $4.64 $6.00 $4.90 $5.49 $0.00 $0.00